This is definitely a long term for me. we started to keep one line "Multibiotic" 6 months ago and we receive very good feedback from our customer. I would said 50% of our customers are switching from Inner Health Plus (less strain) and Ultrabiotic (more expensive) to Multibiotic. the sales went up triple and now we have 3 shelf of Medlab product in my pharmacy. I'm patiently waiting to see their revenue as I can see more store are keeping their product. If he can make Bioceutical top brand, he can make Medlab too.
- Forums
- ASX - By Stock
- MDC
- Ann: Operations Update - Strong Increase in Revenue
Ann: Operations Update - Strong Increase in Revenue, page-12
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MDC (ASX) to my watchlist
|
|||||
Last
$6.60 |
Change
0.000(0.00%) |
Mkt cap ! $15.07M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
MDC (ASX) Chart |
Day chart unavailable
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online